Regeneron Pharmaceuticals Inc (REGN)
Return on equity (ROE)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 4,578,000 | 4,458,600 | 4,499,300 | 4,412,600 | 4,654,500 | 4,321,700 | 3,857,800 | 3,953,600 | 3,991,100 | 4,299,000 | 4,182,700 | 4,338,400 | 5,370,300 | 5,686,800 | 7,933,600 | 8,075,300 | 6,995,500 | 6,205,400 | 4,003,800 | 3,513,200 |
| Total stockholders’ equity | US$ in thousands | 30,957,800 | 29,938,900 | 29,387,600 | 29,353,600 | 29,325,900 | 28,205,800 | 26,991,100 | 25,973,100 | 24,904,400 | 24,017,900 | 23,495,200 | 22,664,000 | 21,438,800 | 20,687,800 | 19,914,700 | 18,768,800 | 17,258,000 | 15,127,300 | 11,977,000 | 11,025,300 |
| ROE | 14.79% | 14.89% | 15.31% | 15.03% | 15.87% | 15.32% | 14.29% | 15.22% | 16.03% | 17.90% | 17.80% | 19.14% | 25.05% | 27.49% | 39.84% | 43.03% | 40.53% | 41.02% | 33.43% | 31.86% |
September 30, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $4,578,000K ÷ $30,957,800K
= 14.79%
Peer comparison
Sep 30, 2025
Company name
Symbol
ROE
Regeneron Pharmaceuticals Inc
REGN
14.79%
Arrowhead Pharmaceuticals Inc
ARWR
-0.35%
Biomarin Pharmaceutical Inc
BMRN
8.59%
See also:
Regeneron Pharmaceuticals Inc Return on Equity (ROE) (Quarterly Data)